SUMO-1 Modification of Histone Deacetylase 1 (HDAC1) Modulates Its Biological Activities
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Histone deacetylation plays a central role in the regulation of genes linked to virtually all biological processes. This modification reaction is dependent on a family of related histone deacetylases (HDACs), which function as key components of large multiprotein complexes involved in the development of normal and neoplastic cells. The mechanisms regulating HDACs and their roles in such processes are not understood, and these form the major focus for the current study. Here, in the course of assessing possible post-translational modifications of HDAC1, we demonstrated that HDAC1 is a substrate for SUMO-1 (small ubiquitin-related modifier) modification in vitro and in vivo. The HDAC1 lysines targeted for modification were identified as C-terminal Lys-444 and Lys-476, which are also present in mammalian HDAC2 and lower vertebrate HDAC1/2 orthologs yet absent from other HDAC family members, pointing to a means of differential regulation among HDAC proteins. Mutation of these target residues (lysine to arginine substitution) profoundly reduced HDAC1-mediated transcriptional repression in reporter assays without affecting HDAC1 ability to associate with mSin3A and eliminated HDAC1-induced cell cycle and apoptotic responses upon overexpression. Together, the results demonstrate that HDAC1 is modified by SUMO-1, and this modification can dramatically affect HDAC1 activity in a number of surrogate biological assays.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, the activities of class I HDACs are regulated by posttranslational modifications to the C-terminal extension, such as sumoylation (David et al., 2002) and phosphorylation (Tsai and Seto, 2002), which may affect their catalytic activities via an allosteric mechanism and/or by altering their complex forming capabilities.”
From Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases (2004) · cites this paper as David et al., 2002
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lysine 476 at the carboxyl terminus has been shown to be sumoylated and important for enzymatic function of the wild-type protein [20] and the absence of this amino acid in the MommeD5 mutant protein is likely to impair function.”
From A genome-wide screen for modifiers of transgene variegation identifies genes with critical roles in development (2008) · cites this paper as [20]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Histone acetylation and transcriptional regulatory mechanisms
Struhl, K. (1998) · Genes & Development · doi:10.1101/gad.12.5.599 · Cited by 1,815
Retinoblastoma protein recruits histone deacetylase to repress transcription
Brehm, A., Miska, E. A., McCance, D. J., Reid, J. L., Bannister, A. J., & Kouzarides, T. (1998) · Nature · doi:10.1038/35404 · Cited by 1,230
Histone Deacetylase Inhibitors: Inducers of Differentiation or Apoptosis of Transformed Cells
Marks, P. A., Richon, V. M., & Rifkind, R. A. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.15.1210 · Cited by 1,157
ALTERATION OF NUCLEOSOME STRUCTURE AS A MECHANISM OF TRANSCRIPTIONAL REGULATION
Workman, J. L., & Kingston, R. E. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.545 · Cited by 1,129
Role of the histone deacetylase complex in acute promyelocytic leukaemia
Lin, R. J., Nagy, L., Inoue, S., Shao, W., Miller, W. H., & Evans, R. M. (1998) · Nature · doi:10.1038/35895 · Cited by 1,062
SUMO-1 Modification of IκBα Inhibits NF-κB Activation
Desterro, J. M. P., Rodriguez, M. S., & Hay, R. T. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80133-1 · Cited by 1,038
Grignani, F., De Matteis, S., Nervi, C., Tomassoni, L., Gelmetti, V., Cioce, M., Fanelli, M., Ruthardt, M., Ferrara, F. F., Zamir, I., et al. (1998) · Nature · doi:10.1038/35901 · Cited by 1,004
Xue, Y., Wong, J., Moreno, G. T., Young, M. K., Côté, J., & Wang, W. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80299-3 · Cited by 985
Rb Interacts with Histone Deacetylase to Repress Transcription
Luo, R. X., Postigo, A. A., & Dean, D. C. (1998) · Cell · doi:10.1016/s0092-8674(00)80940-x · Cited by 960
Retinoblastoma protein represses transcription by recruiting a histone deacetylase
Magnaghi-Jaulin, L., Groisman, R., Naguibneva, I., Robin, P., Lorain, S., Le Villain, J. P., Troalen, F., Trouche, D., & Harel-Bellan, A. (1998) · Nature · doi:10.1038/35410 · Cited by 909
Research works printed but not linked: 1
- Bertos, N. R., Wang, A. H. & Yang, X. J. (2001) Biochem. Cell Biol. 79, 243-252 · doi:10.1139/o01-032 · Paper page
Cited by
Johnson, E. S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.074118 · Cited by 1,675
SUMO and ubiquitin in the nucleus: different functions, similar mechanisms?
Gill, G. (2004) · Genes & Development · doi:10.1101/gad.1214604 · Cited by 756
“SUMO modification of HDAC-1, for example, appears to stimulate deacetylase activity and transcriptional repression by this enzyme (Table 1; David et al. 2002; Cheng et al. 2004).”
BackgroundStructural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases
Somoza, J. R., Skene, R. J., Katz, B. A., Mol, C., Ho, J. D., Jennings, A. J., Luong, C., Arvai, A., Buggy, J. J., Chi, E., et al. (2004) · Structure · doi:10.1016/j.str.2004.04.012 · Cited by 710
Histone Deacetylases: Unique Players in Shaping the Epigenetic Histone Code
THIAGALINGAM, S., CHENG, K., LEE, H. J., MINEVA, N., THIAGALINGAM, A., & PONTE, J. F. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb05964.x · Cited by 700
Mechanisms, regulation and consequences of protein SUMOylation
Wilkinson, K. A., & Henley, J. M. (2010) · Biochemical Journal · doi:10.1042/bj20100158 · Cited by 686
HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics
Gallinari, P., Marco, S. D., Jones, P., Pallaoro, M., & Steinkühler, C. (2007) · Cell Research · doi:10.1038/sj.cr.7310149 · Cited by 678
Nuclear and unclear functions of SUMO
Seeler, J.-S., & Dejean, A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1200 · Cited by 667
Class II histone deacetylases: versatile regulators
Verdin, E., Dequiedt, F., & Kasler, H. G. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(03)00073-8 · Cited by 664
Regulation of transcription factors by neuronal activity
West, A. E., Griffith, E. C., & Greenberg, M. E. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn987 · Cited by 602
“In non-neuronal cells, several members of the HDAC family are subject to post-translational modifications that might affect their enzymatic activit”
The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2
Krämer, O. H., Zhu, P., Ostendorff, H. P., Golebiewski, M., Tiefenbach, J., Peters, M. A., Brill, B., Groner, B., Bach, I., Heinzel, T., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg315 · Cited by 523
Structure–function relationship of estrogen receptor α and β: Impact on human health
Ascenzi, P., Bocedi, A., & Marino, M. (2006) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2006.07.001 · Cited by 499
Something about SUMO inhibits transcription
Gill, G. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.07.004 · Cited by 496
A comprehensive compilation of SUMO proteomics
Hendriks, I. A., & Vertegaal, A. C. O. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.81 · Cited by 514
p300 Transcriptional Repression Is Mediated by SUMO Modification
Girdwood, D., Bumpass, D., Vaughan, O. A., Thain, A., Anderson, L. A., Snowden, A. W., Garcia-Wilson, E., Perkins, N. D., & Hay, R. T. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00141-2 · Cited by 454
“It has recently been(David et al., 2002; Kirsh et al., 2002; Tatham et al., 2001), and while non-modified forms of HDAC1 and HDAC4 demonstrated that Axam/SMT3IP2/SENP2/SSP3 can activate transcription in a PML-dependent fashion (Bestappear to be less active deacetylases, the role of SUMO Live Cell…”
BackgroundModification with SUMO: A role in transcriptional regulation
Verger, A., Perdomo, J., & Crossley, M. (2003) · EMBO reports · doi:10.1038/sj.embor.embor738 · Cited by 440
“Several co-repressors of the histone deacetylase family have been shown to be subject to sumoylation, namely HDAC1, HDAC4 and HDAC6 (David et al., 2002; Kirsh et al., 2002).”
BackgroundSUMO Promotes HDAC-Mediated Transcriptional Repression
Yang, S.-H., & Sharrocks, A. D. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00060-7 · Cited by 353
Regulation of histone deacetylase activities
Sengupta, N., & Seto, E. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20179 · Cited by 346
“Two independent studies [Colombo et al., 2002; David et al., 2002] identified HDAC1as a substrate for SUMO-1modification in vitro and in vivo at Lys444 and Lys476.”
BackgroundResultInfluentialNathan, D., Ingvarsdottir, K., Sterner, D. E., Bylebyl, G. R., Dokmanovic, M., Dorsey, J. A., Whelan, K. A., Krsmanovic, M., Lane, W. S., Meluh, P. B., et al. (2006) · Genes & Development · doi:10.1101/gad.1404206 · Cited by 344
“A third possible mechanism would involve activation of HDACs by sumoylation, which was previously observed ( David et al. 2002; Cheng et al. 2004); thus, lowered HDAC sumoylation (particularly in the SUMO pathway mutant strains) may indirectly lead to higher histone acetylation.”
BackgroundInfluentialSUMO: a regulator of gene expression and genome integrity
Müller, S., Ledl, A., & Schmidt, D. (2004) · Oncogene · doi:10.1038/sj.onc.1207415 · Cited by 283
“It will be crucial to determine the particular function of SUMOylated p53/Mdm2 in the nucleolar compartment.”
BackgroundInfluentialSUMO: A Multifaceted Modifier of Chromatin Structure and Function
Cubeñas-Potts, C., & Matunis, M. J. (2013) · Developmental Cell · doi:10.1016/j.devcel.2012.11.020 · Cited by 281
“Sumoylation of HDAC1 and HDAC4 is required for the full transcriptional repression activities at defined promoters (Cheng et al., 2004; David et al., 2002; Kirsh et al., 2002).”
BackgroundJürgen Dohmen, R. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.09.021 · Cited by 270
Transcriptional regulation by C-terminal binding proteins
Chinnadurai, G. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.01.025 · Cited by 263
Dynamic Interplay of the SUMO and ERK Pathways in Regulating Elk-1 Transcriptional Activity
Yang, S.-H., Jaffray, E., Hay, R. T., & Sharrocks, A. D. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00265-x · Cited by 253
Collaborative spirit of histone deacetylases in regulating chromatin structure and gene expression
Yang, X.-J., & Seto, E. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(03)00015-7 · Cited by 241
Sumoylation of the Estrogen Receptor α Hinge Region Regulates Its Transcriptional Activity
Sentis, S., Le Romancer, M., Bianchin, C., Rostan, M.-C., & Corbo, L. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0042 · Cited by 237
Van Damme, E., Laukens, K., Dang, T. H., & Van Ostade, X. (2010) · International Journal of Biological Sciences · doi:10.7150/ijbs.6.51 · Cited by 219
Role of Desumoylation in the Development of Prostate Cancer
Cheng, J., Bawa, T., Lee, P., Gong, L., & Yeh, E. T. H. (2006) · Neoplasia · doi:10.1593/neo.06445 · Cited by 215
“The transrepressors HDAC1 and HDAC4werealso found tobe sumoylated [25,47,48].”
BackgroundSadakierska-Chudy, A., & Filip, M. (2015) · Neurotoxicity Research · doi:10.1007/s12640-014-9508-6 · Cited by 201
“A second mechanism could rely on HDAC activation by SUMO because it was observed that lowered HDAC sumoylation may indirectly lead to higher histone acetylation (David et al. 2002; Cheng et al. 2004).”
BackgroundThe role of epigenetic processes in controlling flowering time in plants exposed to stress
Yaish, M. W., Colasanti, J., & Rothstein, S. J. (2011) · Journal of Experimental Botany · doi:10.1093/jxb/err177 · Cited by 200
“DNA methylation occurs by covalently adding a methyl group to cytosine of the DNA backbone, while histone modifications occur when specific lysine or arginine residues within the amino acid terminal tail of histones are post-translationally modified either by acetylation (Grunstein, 1997), ADP-ribosylation (Tanigawa e…”
BackgroundHistone deacetylase HDAC1/HDAC2-controlled embryonic development and cell differentiation
Brunmeir, R., Lagger, S., & Seiser, C. (2009) · The International Journal of Developmental Biology · doi:10.1387/ijdb.082649rb · Cited by 197
Signaling chromatin to make muscle
McKinsey, T. A., Zhang, C. L., & Olson, E. N. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00389-7 · Cited by 198
Humphrey, J. S., Price, K., Gupta, E., Baxter, A., Bird, J., Sonnichsen, D., & Naglich, J. (2003) · Chemoradiation in Cancer Therapy · doi:10.1007/978-1-59259-325-5_21 · Cited by 193
A Mechanism for Inhibiting the SUMO Pathway
Boggio, R., Colombo, R., Hay, R. T., Draetta, G. F., & Chiocca, S. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.11.007 · Cited by 189
Sumo and the cellular stress response
Enserink, J. M. (2015) · Cell Division · doi:10.1186/s13008-015-0010-1 · Cited by 189
“5g); for example, sumoylation of HDAC1 promotes transcriptional repression in vivo [81].”
BackgroundHDAC1 Acetylation Is Linked to Progressive Modulation of Steroid Receptor-Induced Gene Transcription
Qiu, Y., Zhao, Y., Becker, M., John, S., Parekh, B. S., Huang, S., Hendarwanto, A., Martinez, E. D., Chen, Y., Lu, H., et al. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.04.019 · Cited by 162
Kubota, T., Matsuoka, M., Chang, T.-H., Tailor, P., Sasaki, T., Tashiro, M., Kato, A., & Ozato, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804479200 · Cited by 174
Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation
Gaughan, L. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki141 · Cited by 174
“For HDAC1, a C-terminal lysine-rich sequence corresponding to residues 432–482 downstream of a PEST sequence has been shown to be hyperubiquitylated in vitro (36).”
BackgroundRETRACTED: The E3 SUMO Ligase PIASy Is a Regulator of Cellular Senescence and Apoptosis
Bischof, O., Schwamborn, K., Martin, N., Werner, A., Sustmann, C., Grosschedl, R., & Dejean, A. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.016 · Cited by 173
RetractedCheng, J., Wang, D., Wang, Z., & Yeh, E. T. H. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.6021-6028.2004 · Cited by 173
“Mutation of two sumoylation sites of HDAC1 greatly reduced HDAC1-mediated transcriptional repression (5).”
BackgroundInfluentialBettermann, K., Benesch, M., Weis, S., & Haybaeck, J. (2012) · Cancer Letters · doi:10.1016/j.canlet.2011.10.036 · Cited by 168
SUMO association with repressor complexes, emerging routes for transcriptional control
Garcia-Dominguez, M., & Reyes, J. C. (2009) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2009.07.001 · Cited by 166
SUMO and transcriptional regulation
Girdwood, D. W. H., Tatham, M. H., & Hay, R. T. (2004) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2003.12.001 · Cited by 164
Ouyang, J., Shi, Y., Valin, A., Xuan, Y., & Gill, G. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.03.013 · Cited by 161
“Notably, several subunits of the LSD1/CoREST1/HDAC complex including HDAC1, LSD1, ZnF198, and CtBP have been reported to be SUMOylated (David et al., 2002; Gocke et al., 2005; Kagey et al., 2003; Kunapuli et al., 2006).”
BackgroundLing, Y. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh195 · Cited by 155
“Studies of HDAC1 and HDAC4 have shown that mutation of the sumoylation sites reduces their capacity to repress transcription ( 50 ,51).”
BackgroundRegulating the Regulators: The Post‐Translational Code of Class I HDAC1 and HDAC2
Segré, C. V., & Chiocca, S. (2011) · BioMed Research International · doi:10.1155/2011/690848 · Cited by 153
“Moreover, overexpression of wild type HDAC1, but not of the 2R mutant, induced accumulation of cells in the G2 phase of the cell cycle, suggesting that the SUMOylation mutant of HDAC1 is impaired in some biological functions [75].”
InfluentialHistone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8
Yan, W., Liu, S., Xu, E., Zhang, J., Zhang, Y., Chen, X., & Chen, X. (2013) · Oncogene · doi:10.1038/onc.2012.81 · Cited by 153
“The C-terminal domain in HDAC1-3 is necessary for interacting with other proteins and for cellular localization (13) and posttranslational modifications (14, 15).”
BackgroundSumoylation of MITF and Its Related Family Members TFE3 and TFEB
Miller, A. J., Levy, C., Davis, I. J., Razin, E., & Fisher, D. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411757200 · Cited by 152
Negative regulation of histone deacetylase 8 activity by cyclic AMP-dependent protein kinase A
Lee, H., Rezai-Zadeh, N., & Seto, E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.2.765-773.2004 · Cited by 153
“For example, HDAC1 is a substrate for SUMO-1 (small ubiquitin-related modifier 1), and mutations of the target residues decrease transcriptional repression without affecting the ability of HDAC1 to associate with mSin3 ( 10 ).”
BackgroundKim, J., Cantwell, C. A., Johnson, P. F., Pfarr, C. M., & Williams, S. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207235200 · Cited by 146
Kuppuswamy, M. N., Vijayalingam, S., Zhao, L., Zhou, Y., Subramanian, T., Ryerse, J. S., & Chinnadurai, G. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01077-07 · Cited by 151
“Thus, our results have illuminated how the recruitment of CtBP1 by a prototypical PLDLS-containing transcription factor could target histone-modifying enzymes, such as HDAC1/2, to the chromatin.”
BackgroundInfluentialEffect of posttranslational modifications on enzyme function and assembly
Ryšlavá, H., Hýsková, V., Kavan, D., & Vaněk, O. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.03.025 · Cited by 171
Weiss, K., Terhal, P. A., Cohen, L., Bruccoleri, M., Irving, M. D., Martinez, A. F., Rosenfeld, J. A., Machol, K., Yang, Y., Liu, P., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.08.001 · Cited by 157
Yamashita, D., Yamaguchi, T., Shimizu, M., Nakata, N., Hirose, F., & Osumi, T. (2004) · Genes to Cells · doi:10.1111/j.1365-2443.2004.00786.x · Cited by 139
“2003) and a few HDACs (David et al. 2002; Kirsh et al. 2002), are also modified by SUMO.”
BackgroundGorski, P. A., Jang, S. P., Jeong, D., Lee, A., Lee, P., Oh, J. G., Chepurko, V., Yang, D. K., Kwak, T. H., Eom, S. H., et al. (2019) · Circulation Research · doi:10.1161/circresaha.118.313865 · Cited by 148
Saldanha, S. N., Kala, R., & Tollefsbol, T. O. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.01.024 · Cited by 129
“In addition, HDACs are known to undergo several post-translational modifications, of which acetylation, phosphorylation, sumoylation and ubiquitination have been reported to occur with HDAC1 that can affect their activity and stability [38].”
BackgroundCao, D., Bromberg, P. A., & Samet, J. M. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0449oc · Cited by 143
“HDACs that are modified with these groups have altered transcriptional repression activity (38, 39), lose the ability to interact with transcription factors (36), or are targeted for degradation (40).”
BackgroundThe Nuclear Receptor Interaction Domain of GRIP1 Is Modulated by Covalent Attachment of SUMO-1
Kotaja, N., Karvonen, U., Jänne, O. A., & Palvimo, J. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204768200 · Cited by 130
Ashe, A., Morgan, D. K., Whitelaw, N. C., Bruxner, T. J., Vickaryous, N. K., Cox, L. L., Butterfield, N. C., Wicking, C., Blewitt, M. E., Wilkins, S. J., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-12-r182 · Cited by 117
“Lysine 476 at the carboxyl terminus has been shown to be sumoylated and important for enzymatic function of the wildtype protein [20] and the absence of this amino acid in the MommeD5 mutant protein is likely to impair function.”
BackgroundKurtev, V., Margueron, R., Kroboth, K., Ogris, E., Cavaillès, V., & Seiser, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312300200 · Cited by 120
Daxx Mediates the Small Ubiquitin-like Modifier-dependent Transcriptional Repression of Smad4
Chang, C., Lin, D.-Y., Fang, H.-I., Chen, R., & Shih, H.-M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409161200 · Cited by 114
Novatchkova, M., Budhiraja, R., Coupland, G., Eisenhaber, F., & Bachmair, A. (2004) · Planta · doi:10.1007/s00425-004-1370-y · Cited by 112
“Many enzymes of DNA metabolism (histone deacetylases, topoisomerases, enzymes of DNA repair), and chromatin proteins including histones can be sumoylation substrates in vivo (e.g., Bachant et al. 2002; David et al. 2002; Rallabhandi et al. 2002; Shiio and Eisenman 2003).”
BackgroundTakahashi, H., Hatakeyama, S., Saitoh, H., & Nakayama, K. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408130200 · Cited by 112
A role for SUMO modification in transcriptional repression and activation
Lyst, M. J., & Stancheva, I. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351389 · Cited by 118
“For example the de novo DNA methyltransferase Dnmt3a [6] is reported to be a substrate for SUMO modification as are a number of histone deacetylases [7, 8] as well as a histone acetyltransferase Gcn5 [9] and a histone methyltransferase Clr4 [10].”
BackgroundGopal, Y. N. V., Arora, T. S., & Dyke, M. W. V. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.06.007 · Cited by 120
C-terminal binding proteins: central players in development and disease
Stankiewicz, T. R., Gray, J. J., Winter, A. N., & Linseman, D. A. (2014) · Biomolecular Concepts · doi:10.1515/bmc-2014-0027 · Cited by 107
PIAS1-mediated Sumoylation of Focal Adhesion Kinase Activates Its Autophosphorylationn
Kadaré, G., Toutant, M., Formstecher, E., Corvol, J.-C., Carnaud, M., Boutterin, M.-C., & Girault, J.-A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308562200 · Cited by 108
An expression screen reveals modulators of class II histone deacetylase phosphorylation
Chang, S., Bezprozvannaya, S., Li, S., & Olson, E. N. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503275102 · Cited by 108
Histone Modifications in Alzheimer’s Disease
Santana, D. A., Smith, M. D. A. C., & Chen, E. (2023) · Genes · doi:10.3390/genes14020347 · Cited by 118
“SUMOylation of HDAC1 has been found on Lys-444 and Lys-476 and seems to regulate its biological activity [136].”
BackgroundRepression of Smad transcriptional activity by PIASy, an inhibitor of activated STAT
Long, J., Matsuura, I., He, D., Wang, G., Shuai, K., & Liu, F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1733973100 · Cited by 107
Histone deacetylases: salesmen and customers in the post‐translational modification market
Brandl, A., Heinzel, T., & Krämer, O. H. (2009) · Biology of the Cell · doi:10.1042/bc20080158 · Cited by 107
“In 2002, two groups described SUMO1 modification of HDAC1 and showed that Lys444 and Lys476 are the main acceptor sites in vitro as well as in vivo (Colombo et al., 2002; David et al., 2002).”
BackgroundInfluentialZNF198 Stabilizes the LSD1–CoREST–HDAC1 Complex on Chromatin through Its MYM-Type Zinc Fingers
Gocke, C. B., & Yu, H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003255 · Cited by 117
“mutant of HDAC1 also shows lower deacetylase activity [37,48], suggesting that sumoylation is required for the full activation of the catalytic activity of HDAC1.”
BackgroundResultInfluentialSumoylation of Mdm2 by Protein Inhibitor of Activated STAT (PIAS) and RanBP2 Enzymes
Miyauchi, Y., Yogosawa, S., Honda, R., Nishida, T., & Yasuda, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208319200 · Cited by 131
Does chromatin remodeling mark systemic acquired resistance?
van den Burg, H. A., & Takken, F. L. W. (2009) · Trends in Plant Science · doi:10.1016/j.tplants.2009.02.003 · Cited by 113
Ledl, A., Schmidt, D., & Müller, S. P. (2005) · Oncogene · doi:10.1038/sj.onc.1208539 · Cited by 112
“In the context of this model it is interesting to note that SUMO modification has recently been reported to recruit HDACs to transcriptional regulators (Girdwood et al., 2003; Yang and Sharrocks, 2004) and that HDACs also undergo SUMOylation (David et al., 2002; Kirsh et al., 2002).”
BackgroundTranscription and beyond: the role of mammalian class I lysine deacetylases
Moser, M., Hagelkrüys, A., & Seiser, C. (2013) · Chromosoma · doi:10.1007/s00412-013-0441-x · Cited by 103
“For instance, HDAC1 can be sumoylated (Colombo et al. 2002; David et al. 2002), but only SUMO1 and not SUMO2 conjugation to HDAC1 promotes its ubiquitination and degradation (Citro et al. 2013).”
BackgroundPosttranslational modifications of histone deacetylases: Implications for cardiovascular diseases
Eom, G. H., & Kook, H. Y. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.012 · Cited by 105
SUMO‐regulated transcription: Challenging the dogma
Chymkowitch, P., Aurélie Nguéa, P., & Enserink, J. M. (2015) · BioEssays · doi:10.1002/bies.201500065 · Cited by 102
“HDAC1 Vertebrates K444, K476 Negative [115]”
Physical and functional interactions of histone deacetylase 3 with TFII-I family proteins and PIASxβ
Tussié-Luna, M. I., Bayarsaihan, D., Seto, E., Ruddle, F. H., & Roy, A. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192464499 · Cited by 113
Mosley, A. L., & Özcan, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410379200 · Cited by 93
SUMO Modification Is Involved in the Maintenance of Heterochromatin Stability in Fission Yeast
Shin, J. A., Choi, E. S., Kim, H. S., Ho, J. C.-Y., Watts, F. Z., Park, S. D., & Jang, Y. K. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.08.021 · Cited by 107
“, 2003), or modulate activities of histone deacetylases (David et al., 2002; Kirsh et al., 2002) and histone acetyltransferase p300 (Girdwood et al.”
BackgroundChfr is linked to tumour metastasis through the downregulation of HDAC1
Oh, Y. M., Kwon, Y. E., Kim, J. M., Bae, S. J., Lee, B. K., Yoo, S. J., Chung, C. H., Deshaies, R. J., & Seol, J. H. (2009) · Nature Cell Biology · doi:10.1038/ncb1837 · Cited by 89
“HDAC1 H141A , a mutant that lacks deacetylase activit”
BackgroundFoglietti, C., Filocamo, G., Cundari, E., De Rinaldis, E., Lahm, A., Cortese, R., & Steinkühler, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511945200 · Cited by 90
Poon, A. P. W., Liang, Y., & Roizman, B. (2003) · Journal of Virology · doi:10.1128/jvi.77.23.12671-12678.2003 · Cited by 90
“We should note that an extensive literature indicates that the activity of HDAC1 and HDAC2 is regulated by Sumo-1 modification and by phosphorylation by cyclic AMP-dependent kinase and casein kinase 2 (6, 40, 51).”
BackgroundLi, X., Song, S., Liu, Y., Ko, S.-H., & Kao, H.-Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405179200 · Cited by 88
The adenovirus protein Gam1 interferes with sumoylation of histone deacetylase 1
Colombo, R., Boggio, R., Seiser, C., Draetta, G. F., & Chiocca, S. (2002) · EMBO Reports · doi:10.1093/embo-reports/kvf213 · Cited by 100
“These findings are in agreement with data published recently (David et al., 2002).”
BackgroundResultInfluentialBawa‐Khalfe, T., Cheng, J., Wang, Z., & Yeh, E. T. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706978200 · Cited by 86
Role for SUMO Modification in Facilitating Transcriptional Repression by BKLF
Perdomo, J., Verger, A., Turner, J. J. O., & Crossley, M. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.4.1549-1559.2005 · Cited by 87
“pGBT9-BKLF (1-268) has been described previously (62).”
BackgroundStimulation of Histone Deacetylase Activity by Metabolites of Intermediary Metabolism
Vogelauer, M., Krall, A. S., McBrian, M. A., Li, J.-Y., & Kurdistani, S. K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.362467 · Cited by 81
“Sumoylation of HDAC1 increases its enzymatic activity, and phosphorylation of HDAC1 stimulates both its activity and complex formation (17, 18).”
BackgroundXiao, Z., Chang, J.-G., Hendriks, I. A., Sigurðsson, J. O., Olsen, J. V., & Vertegaal, A. C. O. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o114.044792 · Cited by 91
“SUMOylation of HDAC1 and BRCA1 was previously demonstrated to promote enzymatic activity (26, 55), and it would be interesting to determine the functional relevance of SUMOylation for these other SUMO target proteins.”
BackgroundFeng, D., Sangster-Guity, N., Stone, R., Korczeniewska, J., Mancl, M. E., Fitzgerald-Bocarsly, P., & Barnes, B. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000482 · Cited by 80
Chupreta, S., Holmstrom, S. R., Subramanian, L., & Iñiguez-Lluhı́, J. A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.10.4272-4282.2005 · Cited by 80
“In addition to mediating the effects of SC motifs, SUMOylation plays important roles at other steps of transcriptional regulation since both positive and negative coregulators (histone deacetylases, P300, GRIP1, SRC-1, CtBP), as well as histones, are SUMOylated ( 8 , 12, 30, 31, 43).”
BackgroundMethodDefective sumoylation pathway directs congenital heart disease
Wang, J., Chen, L., Wen, S., Zhu, H., Yu, W., Moskowitz, I. P. G., Shaw, G. M., Finnell, R. H., & Schwartz, R. J. (2011) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.20816 · Cited by 88
“A number of chromatin remodeling factors have been identified as SUMO conjugation substrates (David et al., 2002; Kirsh et al., 2002; Ling et al., 2004).”
BackgroundTrans-regulation of Histone Deacetylase Activities through Acetylation
Luo, Y., Jian, W., Stavreva, D., Fu, X., Hager, G., Bungert, J., Huang, S., & Qiu, Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.038356 · Cited by 78
Siatecka, M., Li, X., & Bieker, J. J. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00589-07 · Cited by 93
“For example, sumoylation of HDAC1 and HDAC4 leads to enhancement of their repressive activities as compared to nonmodified forms (10, 32).”
BackgroundThe SUMO system: a master organizer of nuclear protein assemblies
Raman, N., Nayak, A., & Müller, S. P. (2013) · Chromosoma · doi:10.1007/s00412-013-0429-6 · Cited by 83
“Interestingly, LSD1 and HDAC1 itself have also been reported to be SUMOylated again indicating that SUMOdependent assembly of transcriptional regulatory complexes might be a synergistic process (David et al. 2002).”
BackgroundSumoylation and Regulation of Cardiac Gene Expression
Wang, J., & Schwartz, R. J. (2010) · Circulation Research · doi:10.1161/circresaha.110.220491 · Cited by 77
Evolution of the arginase fold and functional diversity
Dowling, D. P., Di Costanzo, L., Gennadios, H. A., & Christianson, D. W. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7554-z · Cited by 74
Varotto, S., Locatelli, S., Canova, S., Pipal, A., Motto, M., & Rossi, V. (2003) · PLANT PHYSIOLOGY · doi:10.1104/pp.103.025403 · Cited by 73
“…modifications of animal HDACs such as phosphorylation and sumoylation, besides their function in modulating HDAC activity and complex formation, might act as signals to increase or decrease protein stability and the degree of protein degradation (Pflum et al., 2001; David et al., 2002).”
BackgroundHistone deacetylase complexes: Structure, regulation and function
Asmamaw, M. D., He, A., Zhang, L., Liu, H., & Gao, Y. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189150 · Cited by 85
Mukherjee, P. K., Pradhan, A., Shah, F., Tekwani, B. L., & Avery, M. A. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.03.005 · Cited by 74
Metadata
- Authors
- David, G., Neptune, M. A., & DePinho, R. A.
- Affiliations
- Harvard University (US)
- Corresponding author
- DePinho, Ronald A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-06
- Volume
- 277
- Issue
- 26
- Pages
- 23658-23663
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2129063436
- Cited by
- 236
- References
- 36
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 4 · 2023: 2 · 2022: 2 · 2021: 6 · 2020: 5 · 2019: 6 · 2018: 6 · 2017: 9 · 2016: 5 · 2015: 7 · 2014: 11 · 2013: 11 · 2012: 7
- FWCI
- 7.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6719 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- American Cancer Society
- National Institutes of Health
- National Cancer Institute (R01CA086379)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- SUMO1, HDAC1, post-translational modification, lysine modification, histone deacetylation, transcriptional repression, mSin3A, cell cycle regulation, apoptosis, HDAC2
- MeSH terms
- Animals, Histone Deacetylases, Lysine, Structure-Activity Relationship, 3T3 Cells, Ubiquitin, SUMO-1 Protein, Mice, Histone Deacetylase 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.